Page last updated: 2024-08-24

valsartan and Kidney Failure

valsartan has been researched along with Kidney Failure in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (9.09)	18.2507
2000's	9 (40.91)	29.6817
2010's	10 (45.45)	24.3611
2020's	1 (4.55)	2.80

Authors

Authors	Studies
Bedhomme, S; Bouchant, S; Boussageon, R; Bœuf-Gibot, S; Charuel, E; Menini, T; Pereira, B; Piñol-Domenech, N; Vaillant-Roussel, H	1
Ayalasomayajula, S; Boggarapu, S; Langenickel, T; Pal, P; Sunkara, G	1
Ahmad, SNS; Argani, H; Aslani, S; Ghorbani Haghjo, A; Jigheh, ZA; Mesgari Abbasi, M; Panah, F; Rashedi, J; Roshangar, L; Sanajou, D	1
Barreira, JC; Iotti, A; Laborde, HA; Rivero, MA; Zazzetti, F	1
Jacob, MS; Sabe, MA; Taylor, DO	1
Anand, I; Andreka, P; Charney, A; Chen, F; Cosmi, F; Fischer, S; Galve, E; Gelev, V; Gogia, H; Gómez-Doblas, JJ; Majercak, I; Martinez-Selles, M; McIntyre, HF; McMurray, JJ; Nociar, J; Radomska, M; Reimund, B; Reyes, A; Sarkar, A; Senni, M; Shehova-Yankova, N; Sokolova, B; Volterrani, M; Wachter, R; Yilmaz, MB; Zilahi, Z	1
Albrecht, D; Ayalasomayajula, SP; Chandra, P; Jordaan, P; Langenickel, TH; Pal, P; Rajman, I; Sunkara, G; Zhou, W	1
Cheng, J	1
Friedrich, D; Gortner, L; Herkenrath, P; Hoppe, B; Hünseler, C; Kattner, E; Körber, F; Lindner, U; Müller, A; Oberthuer, A; Paneitz, A; Roth, B; Schaible, T; Schmitt, K; Welzing, L	1
Bains, J; Smith, WB	1
Maksimov, ML; Mochkin, IA; Starodubtsev, AK	1
Bos-Thompson, MA; Boulot, P; Dechaud, H; Hillaire-Buys, D; Mazurier, E; Morin, D; Muller, F	1
Ripley, TL	1
Böger, RH; Maas, R; Quispe-Bravo, S; Schwedhelm, E; Skamira, C	1
Ruilope, LM	1
Madelenat, P; Mahieu-Caputo, D; Popovic, I; Roger, N	1
Goa, KL; Markham, A	1
Mann, JF	1
Agarwal, R; Bakris, GL; Bolton, WK; Catanzaro, D; Hebert, L; Janssen, I; Richardson, D; Siomos, M	1
Tepel, M; van der Giet, M; Zidek, W	1
Hollenberg, NK	1
Armstrong, PW; Borer, J; Fleming, T; Lipicky, R	1

Reviews

9 review(s) available for valsartan and Kidney Failure

Article	Year
Benefits and adverse effects of sacubitril/valsartan in patients with chronic heart failure: A systematic review and meta-analysis. Pharmacology research & perspectives, 2021, Volume: 9, Issue:5 Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Chronic Disease; Drug Combinations; Heart Failure; Hospitalization; Humans; Hyperkalemia; Hypotension; Mortality; Renal Insufficiency; Risk Assessment; Stroke Volume; Valsartan	2021
Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor. Clinical pharmacokinetics, 2017, Volume: 56, Issue:12 Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Area Under Curve; Biphenyl Compounds; Drug Combinations; Drug Interactions; Heart Failure; Humans; Liver Diseases; Renal Insufficiency; Tetrazoles; Valsartan	2017
Valsartan plus hydrochlorothiazide: a review of its use since its introduction. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:12 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Diuretics; Drug Combinations; Drug Costs; Drug Synergism; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Renal Insufficiency; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left	2011
[Application of AT1-angiotensin II receptor blocker valsartan in clinical practice]. Kardiologiia, 2011, Volume: 51, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Drug Monitoring; Heart Failure; Humans; Hypertension; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renal Insufficiency; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Water-Electrolyte Balance	2011
Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:1 Topics: Amniotic Fluid; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; beta 2-Microglobulin; Child, Preschool; Female; Follow-Up Studies; Gestational Age; Humans; Hypertension; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Renal Insufficiency; Tetrazoles; Valine; Valsartan	2005
Valsartan in chronic heart failure. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:3 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Drug Therapy, Combination; Female; Formularies, Hospital as Topic; Heart Failure; Humans; Liver Diseases; Male; Patient Education as Topic; Pregnancy; Randomized Controlled Trials as Topic; Renal Insufficiency; Tetrazoles; Valine; Valsartan	2005
New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:2 Suppl Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Diabetes Complications; Diabetic Neuropathies; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney Diseases; Renal Insufficiency; Tetrazoles; Valine; Valsartan	2000
Valsartan. A review of its pharmacology and therapeutic use in essential hypertension. Drugs, 1997, Volume: 54, Issue:2 Topics: Antihypertensive Agents; Cardiomegaly; Humans; Hypertension; Receptors, Angiotensin; Renal Insufficiency; Tetrazoles; Valine; Valsartan	1997
Valsartan and the kidney: present and future. Journal of cardiovascular pharmacology, 1999, Volume: 33 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Humans; Hypertension; Kidney Diseases; Renal Insufficiency; Tetrazoles; Valine; Valsartan	1999

Trials

4 trial(s) available for valsartan and Kidney Failure

Article	Year
A new class of drugs for systolic heart failure: The PARADIGM-HF study. Cleveland Clinic journal of medicine, 2015, Volume: 82, Issue:10 Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiovascular Diseases; Cough; Double-Blind Method; Drug Combinations; Enalapril; Female; Heart Failure, Systolic; Hospitalization; Humans; Hyperkalemia; Hypotension; Male; Middle Aged; Neprilysin; Renal Insufficiency; Tetrazoles; Valsartan	2015
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens. European journal of heart failure, 2016, Volume: 18, Issue:9 Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Double-Blind Method; Drug Combinations; Female; Heart Failure; Humans; Hyperkalemia; Hypotension; Male; Middle Aged; Neprilysin; Renal Insufficiency; Tetrazoles; Treatment Outcome; Valsartan	2016
Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor. European journal of clinical pharmacology, 2016, Volume: 72, Issue:9 Topics: Adult; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Renal Insufficiency; Tetrazoles; Valsartan	2016
ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. Kidney international, 2000, Volume: 58, Issue:5 Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Female; Glomerular Filtration Rate; Humans; Kidney; Lisinopril; Male; Middle Aged; Potassium; Renal Insufficiency; Tetrazoles; Valine; Valsartan	2000

Other Studies

9 other study(ies) available for valsartan and Kidney Failure

Article	Year
FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats. Journal of physiology and biochemistry, 2018, Volume: 74, Issue:3 Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Benzamides; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Glomerular Filtration Barrier; Injections, Intraperitoneal; Macrophages; Male; Microscopy, Fluorescence; Phosphorylation; Podocytes; Protein Processing, Post-Translational; Random Allocation; Rats, Wistar; Receptor for Advanced Glycation End Products; Renal Insufficiency; Transcription Factor RelA; Valsartan	2018
Scleroderma renal crisis in an elderly patient with overlap syndrome. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2013, Volume: 19, Issue:7 Topics: Aged; Biopsy; Enalapril; Female; Humans; Hypertension; Kidney; Renal Dialysis; Renal Insufficiency; Scleroderma, Systemic; Sjogren's Syndrome; Tetrazoles; Treatment Outcome; Valine; Valsartan	2013
Sacubitril/Valsartan (Entresto) for Heart Failure. American family physician, 2016, Oct-15, Volume: 94, Issue:8 Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Biphenyl Compounds; Chronic Disease; Drug Combinations; Heart Failure; Humans; Hyperkalemia; Hypotension; Neprilysin; Renal Insufficiency; Severity of Illness Index; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan	2016
Angiotensin II receptor blocker induced fetopathy: 7 cases. Klinische Padiatrie, 2011, Volume: 223, Issue:1 Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Apgar Score; Benzimidazoles; Biphenyl Compounds; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; Hypertension, Pulmonary; Imidazoles; Infant, Newborn; Kidney; Lung; Male; Oligohydramnios; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Renal Insufficiency; Skull; Tetrazoles; Ultrasonography, Prenatal; Valine; Valsartan	2011
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study. Vascular medicine (London, England), 2005, Volume: 10 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzimidazoles; Benzoates; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Endothelium, Vascular; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Oxidative Stress; Randomized Controlled Trials as Topic; Renal Insufficiency; Telmisartan; Tetrazoles; Valine; Valsartan	2005
[Fetal toxicity of angiotensin-II-receptor inhibitors. Case report]. Gynecologie, obstetrique & fertilite, 2007, Volume: 35, Issue:6 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Female; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Renal Insufficiency; Tetrazoles; Valine; Valsartan	2007
Efficacy and tolerability of angiotensin II type 1 receptor antagonists in dialysis patients using AN69 dialysis membranes. Kidney & blood pressure research, 2001, Volume: 24, Issue:1 Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Drug Tolerance; Female; Humans; Hypertension; Male; Membranes, Artificial; Middle Aged; Renal Dialysis; Renal Insufficiency; Tetrazoles; Valine; Valsartan	2001
ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. Current hypertension reports, 2001, Volume: 3, Issue:3 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Humans; Lisinopril; Potassium; Renal Insufficiency; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan	2001
Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001. Circulation, 2001, Oct-30, Volume: 104, Issue:18 Topics: Adrenergic beta-Antagonists; Advisory Committees; Age Factors; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black People; Canada; Cardiovascular Agents; Drug Approval; Heart Failure; Humans; Hyperkalemia; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 1; Renal Insufficiency; Spironolactone; Survival Rate; Tetrazoles; United States; United States Food and Drug Administration; Valine; Valsartan	2001